The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Women reporting at least 50 moderate to severe vasomotor symptoms per week, recorded for seven consecutive days

Aged 40 to 70 years

Exclusion Criteria:

No estrogen monotherapy or estrogen/progesterone containing drug products within applicable wash out period prior to screening

Use of SERMs, clonidine within 4 weeks of screening

Use of CNS active medication within 1 week of screening

Use of medications (SSRI; SNRI), herbal or dietary supplements, including black cohosh, soy, phytoestrogens or over the counter agent known to possibly be effective for the treatment of vasomotor symptoms, within 4 weeks of screening